ОБ ЭТОМ ПОДКАСТЕ 🔗

Ведущие:
Частота обновления:
weekly
Средняя продолжительность аудио:
52 minutes
Гостевые интервью
английский
США
82 серий
с 21 марта 2025 г.
episodic

ПОСЛЕДНИЙ ЭПИЗОД 🔗

This week, we have a conversation with Philip Brainin, CEO of Isomab, about restoring blood flow to the heart, and with RougeTx CEO Andrew Lightfoot, about developing a treatment for hereditary haemorrhagic telangiectasia (HHT). Times: 03:34 Isomab 25:29 RougeTx Isomab Isomab, a preclinical UK biot…

ПОИСК ПРОШЛЫХ ЭПИЗОДОВ

Искать прошлые эпизоды Base to Base Biotech.

ПРЕДЫДУЩИЕ ЭПИЗОДЫ

This week, we talk about mitochondria and obesity with Jon Rees, co-founder and CEO of MitoRx Therapeutics, and also have a chat with Apeximmune Therapeutics’ CEO and founder Li-Fen Lee, and senior director of biology Kan Lu, about a new breakthrough in shrinking tumours. Times: 03:11 MitoRx Therap…
This week, we chat with Ryan Beal, a cancer survivor and founder and CEO of Dyve Biosciences, about tumour acidity, and Gene Mack, president and CEO of Gain Therapeutics, about developing allosteric therapies, including taking Parkinson’s disease treatments beyond addressing symptoms. Times: 03:03 …
This week, we chat with Simon Mølgaard, co-founder and chief executive officer of Teitur Trophics about results from its Parkinson’s disease trial, and have a conversation with Jordi Fàbrega, co-founder and CEO of CONNECTA Therapeutics, and Josep Prous, co-founder and chief scientific officer, abou…
This week, we chat with Lucas Decuypere, CEO and president of Allegro, about treatment of knee osteoarthritis with a nanotechnology injection, and Elin Trampe, the CEO of Dicot Pharma, a company developing a new form of erectile dysfunction treatment. Times: 01:46 Dicot Pharma 17:21 Allegro Allegro…
This week, we chat with Evan Appleton, chief scientific officer and co-founder of Intertwined, a company focused on understanding mammalian evolved protective traits, and how they can be transferred to humans. And we chat with Lew Bender, CEO of Intensity Therapeutics, which is pioneering an intrat…
This week, we have conversations with Marc Hedrick, CEO of Cerenome, about a combined approach to tackling central nervous system (CNS) cancers, and Shaun Holt, CEO of Alveo Technologies, about the potential for animal diseases to jump to humans, and what we can do about it. Times: 03:27 Cerenome 2…
Times: 03:17 Asgard Therapeutics 32:43 Waiv This week, we talk to a company in Lund, Asgard Therapeutics, and its co-founder and CEO Cristiana Pires, about in vivo direct cell reprogramming for cancer immunotherapy, and we chat about clinical diagnostics with Meriem Sefta, CEO of Waiv. Asgard Thera…
This week, our guests are Bryan McClellan, who conducted research on pancreatic cancer as a postdoctoral fellow at Dell Medical School, and William Matsui, the study's senior author and former executive vice dean for research at Dell Medical School; and Theialife president and CEO, Thomas Ruggia, a…
This week, our guests are chief scientific officer of Valo Health, Karin Conde-Knape, and Karsten Eastman, CEO of Sethera Therapeutics. Times: 03:06 Sethera Therapeutics 20:08 Valo Health Valo Health Our guest from Valo Health is chief scientific officer Karin Conde-Knape. As head of global drug di…
Отказ от ответственности: Подкаст и иллюстрации, встроенные в эту страницу, взяты из Jim Cornall, который является собственностью его владельца и не связан или не одобрен Listen Notes, Inc.